This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Buckeye Pharmaceuticals. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Alan T Riga - Innovator in Chemical Compound Delivery
Introduction
Alan T Riga is a notable inventor based in Mayfield Heights, OH (US). He has made significant contributions to the field of chemical delivery systems. His innovative approach has led to the development of a unique device that enhances the delivery of chemical compounds.
Latest Patents
Alan T Riga holds 1 patent for a "Chemical compound delivery device and method." This invention provides devices and methods for delivering a chemical compound to, through, or into a membrane, tissue, or layer. The device includes an AC signal source and at least one electrode. In one application, an interdigitated electrode is electrically connected to the AC signal source. The chemical compound, such as a medicament containing a drug, may be disposed on or within the electrode. Logic controls the AC signal source to provide the signal, including setting or selecting characteristics such as voltage and frequency to orient and motivate the chemical compound through the electrode and into the tissue.
Career Highlights
Alan T Riga is currently employed at Buckeye Pharmaceuticals, where he continues to innovate in the field of pharmaceuticals. His work focuses on improving the efficacy of drug delivery systems, which is crucial for enhancing patient outcomes.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues, including Vadim F Lvovich and Michael G Kaufman. These collaborations have further enriched his research and development efforts.
Conclusion
Alan T Riga is a pioneering inventor whose work in chemical compound delivery devices is making a significant impact in the pharmaceutical industry. His innovative solutions are paving the way for more effective drug delivery methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile